Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition.

Skidmore J, Atcha Z, Boucherat E, Castelletti L, Chen DW, Coppo FT, Cutler L, Dunsdon RM, Heath BM, Hutchings R, Hurst DN, Javed S, Martin S, Maskell ES, Norton D, Pemberton DJ, Redshaw S, Rutter R, Sehmi SS, Scoccitti T, Temple HE, Theobald P, Ward RW, Wilson DM.

Bioorg Med Chem Lett. 2012 May 15;22(10):3560-3. doi: 10.1016/j.bmcl.2012.03.040.

PMID:
22503248
2.

Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.

Faghih R, Gfesser GA, Gopalakrishnan M.

Recent Pat CNS Drug Discov. 2007 Jun;2(2):99-106. Review.

PMID:
18221220
4.

Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia.

Hajós M, Rogers BN.

Curr Pharm Des. 2010;16(5):538-54. Review.

PMID:
19909231
5.
6.

Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity.

Bunnelle WH, Dart MJ, Schrimpf MR.

Curr Top Med Chem. 2004;4(3):299-334. Review.

PMID:
14754449
7.

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

Gatto GJ, Bohme GA, Caldwell WS, Letchworth SR, Traina VM, Obinu MC, Laville M, Reibaud M, Pradier L, Dunbar G, Bencherif M.

CNS Drug Rev. 2004 Summer;10(2):147-66. Review.

Items per page

Supplemental Content

Support Center